P
WST icon

Paradiem’s West Pharmaceutical WST Stock Holding History

Paradiem’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,719
Closed -$2.54M – 90
2024
Q2 		$2.54M Sell
7,719
-1,762
-19% -$623K 0.64% 52
2024
Q1 		$3.75M Sell
9,481
-417
-4% -$154K 0.93% 42
2023
Q4 		$3.49M Sell
9,898
-2,680
-21% -$948K 0.97% 47
2023
Q3 		$4.72M Buy
12,578
+611
+5% +$236K 1.42% 30
2023
Q2 		$4.58M Sell
11,967
-815
-6% -$291K 1.3% 30
2023
Q1 		$4.43M Buy
12,782
+1,194
+10% +$349K 1.38% 25
2022
Q4 		$2.73M Sell
11,588
-133
-1% -$31.5K 1.01% 52
2022
Q3 		$2.88M Buy
11,721
+706
+6% +$215K 1.12% 44
2022
Q2 		$3.33M Buy
11,015
+1,140
+12% +$371K 1.26% 30
2022
Q1 		$4.08M Buy
9,875
+52
+0.5% +$20.4K 1.34% 28
2021
Q4 		$3.86M Buy
9,823
+212
+2% +$91.3K 1.26% 29
2021
Q3 		$4.21M Sell
9,611
-48
-0.5% -$20.2K 1.25% 29
2021
Q2 		$4.2M Buy
9,659
+72
+0.8% +$23.8K 1.3% 32
2021
Q1 		$3.16M Buy
9,587
+1,700
+22% +$487K 1.04% 39
2020
Q4 		$2.31M Buy
+7,887
New +$2.21M 0.98% 49

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paradiem's WST Position: Q3 2024 in Review

Paradiem sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 7,719 shares — an estimated $2.54M sold.

Paradiem first reported a position in WST in Q4 2020 and held it in 15 quarters. The position peaked at $4.72M in Q3 2023. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Paradiem reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Paradiem sold 7,719 West Pharmaceutical shares in Q3 2024, an estimated $2.54M.
  • Paradiem first reported a position in West Pharmaceutical in Q4 2020 and held it in 15 quarters.
  • Paradiem's West Pharmaceutical position peaked at $4.72M in Q3 2023.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Paradiem's 13F filing for Q3 2024, filed 24 Oct 2024.